ApicHope Pharmaceutical Co., Ltd (300723.SZ)
- Previous Close
22.89 - Open
21.33 - Bid 22.59 x --
- Ask 22.60 x --
- Day's Range
22.46 - 23.04 - 52 Week Range
17.50 - 34.34 - Volume
5,052,725 - Avg. Volume
5,729,890 - Market Cap (intraday)
10.264B - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
33.73 - EPS (TTM)
0.67 - Earnings Date --
- Forward Dividend & Yield 0.20 (0.88%)
- Ex-Dividend Date May 24, 2023
- 1y Target Est
34.92
ApicHope Pharmaceutical Co., Ltd, together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical drugs. Its pediatric medicines include fuganlin and yiqi jianpi oral liquid, carboxymestrine oral solution, and xiaoer kechuanling oral liquid products; and clindamycin hydrochloride palmitate dispersible tablet, acetylguitaricin dry suspension, qinxiangqingjie oral liquid, levocetirizine hydrochloride drop, epstein hydrochloride granule, clindamycin hydrochloride palmitate granule, clindamycin hydrochloride for injection, clindamycin phosphate injection, ambroxol hydrochloride drop, montelukast sodium granule, acyclovir for injection, and oseltamivir phosphate capsule products. The company's chronic disease drugs comprise hepatocyte growth stimulating hormone and pentoxifylline for injections, kangshen granules, uqingshu granules, shenbai lotion products, compound monoammonium glycyrrhizinate S and lansoprazole for injections, houttuynia sodium tablets, omeprazole sodium and bromhexine hydrochloride for injections, huixinkang tablets, amlodipine benzenesulfonate dispersible tablets, yanhunin and sodium ferulate for injections, cyclic adenosine phosphate and ambroxol hydrochloride for injections, valsartan amlodipine tablets, and nifedipine controlled release tablets, as well as tricorutin, aceglutamide, vinpocetine, and doxofylline for injections. In addition, it offers compound xiangrui water, yinhuang oral liquid, and xiongdan chuanbei oral liquid products; venlafaxine hydrochloride sustained-release capsules; and levofloxacin hydrochloride, sodium ozagrel, brain protein hydrolysate, and ganciclovir for injections. The company was formerly known as Yipinhong Pharmaceutical Co.,Ltd and changed its name to ApicHope Pharmaceutical Co., Ltd in December 2021. ApicHope Pharmaceutical Co., Ltd was founded in 2002 and is based in Guangzhou, China.
www.apichope.com1,386
Full Time Employees
December 31
Fiscal Year Ends
Sector
Related News
Performance Overview: 300723.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300723.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300723.SZ
Valuation Measures
Market Cap
10.26B
Enterprise Value
10.77B
Trailing P/E
33.60
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.10
Price/Book (mrq)
3.94
Enterprise Value/Revenue
4.28
Enterprise Value/EBITDA
30.54
Financial Highlights
Profitability and Income Statement
Profit Margin
12.19%
Return on Assets (ttm)
4.30%
Return on Equity (ttm)
11.20%
Revenue (ttm)
2.52B
Net Income Avi to Common (ttm)
306.67M
Diluted EPS (ttm)
0.67
Balance Sheet and Cash Flow
Total Cash (mrq)
615.59M
Total Debt/Equity (mrq)
41.38%
Levered Free Cash Flow (ttm)
-992.52k
Research Analysis: 300723.SZ
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 300723.SZ
300723.SZ does not have Company Insights